In sleep-deprived mice, cannabinoid treatment reduced nesfatin-1 (an appetite-regulating protein) in the brain through both CB1 and CB2 receptors, while CB2 receptor activation was associated with increased insulin resistance.
People interested in how cannabis affects appetite and metabolism, researchers studying the munchies mechanism.
Cannabinoids reduced brain nesfatin-1 via both CB1 and CB2; CB2 linked to insulin resistance
What the researchers found
WIN 55,212-2 reduced brain nesfatin-1 immunoreactivity in sleep-deprived mice, an effect prevented by either CB1 or CB2 antagonists. Serum nesfatin-1 levels were unchanged. Insulin resistance was higher in the CB2 antagonist and WIN+CB2 antagonist groups, suggesting CB2 involvement in glucose metabolism.
Why it matters
This reveals a new connection between cannabinoid receptors and appetite-regulating signals in the brain. The finding that CB2 receptors affect insulin resistance independently adds to evidence that cannabinoids influence metabolism through multiple pathways.
The numbers in context
60 mice, 72-hour sleep deprivation. WIN reduced brain nesfatin-1 positive cell count. Both CB1 and CB2 antagonists prevented the nesfatin-1 reduction. Serum nesfatin-1 unchanged across groups. Insulin resistance higher in CB2-related groups.
How the study worked
Sixty mice subjected to 72-hour REM sleep deprivation and treated with WIN 55,212-2 (cannabinoid agonist), AM251 (CB1 antagonist), SR144528 (CB2 antagonist), or combinations. Blood glucose, insulin, and nesfatin-1 measured; brain nesfatin-1 assessed by immunohistochemistry.
What this study cannot tell us
Sleep deprivation model adds a confound. Acute drug administration only. Only male mice. The relationship between central nesfatin-1 reduction and actual eating behavior was not tested.
How to read the evidence
Preliminary: animal study with pharmacological dissection of receptor roles, but confounded by sleep deprivation model.
When this study was published
Published in 2019.
The bigger picture
The appetite-stimulating effects of cannabinoids ("the munchies") are well-known but incompletely understood. This study adds nesfatin-1 as another molecular player in cannabinoid appetite regulation, and the insulin resistance finding connects cannabis to metabolic health.
Questions still open
- Does chronic cannabis use alter nesfatin-1 levels in humans? Could the insulin resistance finding explain metabolic effects of long-term cannabis use? Would CBD affect nesfatin-1 differently than THC?
Common questions
How do cannabinoids stimulate appetite?
Can cannabis affect blood sugar?
Read the original research
Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance.
The Chinese journal of physiology, 62(5), 182-187
Citation
Kaya, Oktay; Yilmaz, Makbule Elif; Bayram, Sinasi; Gunduz, Ozgur; Kizilay, Gulnur; Ozturk, Levent. (2019). Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance.. The Chinese journal of physiology, 62(5), 182-187. https://doi.org/10.4103/CJP.CJP_50_19
Explore the wider topic
- Cannabis and Your Cardiovascular System: Heart Risk, Stroke, and What the Research Shows
- Cannabis and Your Heart: What the Cardiovascular Research Shows
- Coughing Up Black Stuff After Quitting Weed: What It Means
- Lung Recovery After Quitting Weed: The Complete Timeline
- Weed and Your Lungs: Recovery Timeline After Quitting
- Quitting Weed as a Woman: Hormones, Cycles, and Recovery
- Cannabis, Weight, and Diet: What Quitting Does to Your Appetite
- Sex After Quitting Weed: What Changes and What Doesn't
- Cannabis and Driving: DUI Laws, Impairment Science, and What You Need to Know
- Weed and Acne: Can Quitting Cannabis Clear Your Skin?
- Weed and Fertility: What Couples Should Know
- Weed and Your Gut: How Cannabis Affects Digestion
- Weed and Your Heart: Cardiovascular Effects and Recovery
- Weed, Testosterone, and Male Health: What the Research Actually Shows